Literature DB >> 176158

Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity.

S Bose, D Gurari-Rotman, U T Ruegg, L Corley, C B Anfinsen.   

Abstract

Human leukocyte and tritium-labeled fibroblast interferons, prepared by induction with Sendai virus and with double-stranded polyinosinic acid.polycytidylic acid respectively, have been studied in relation to the carbohydrate moieties attached to them. These interferons were partially purified by immunoabsorbance and by gel filtration. On treatment with glycosidases, about 80% of the 3H-labeled sugar moieties in this glycoprotein-containing fraction was removed without detectable alteration of the antiviral activity or antibody-binding properties characteristic of interferon. The molecular weight of leukocyte interferon was reduced by about 4000. As others have reported, the heterogeneous character of interferon revealed by isoelectric focusing was greatly reduced by the enzyme treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.

Authors:  W E Stewart; L S Lin; M Wiranowska-Stewart; K Cantell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Stable and unstable forms of human fibroblast interferon.

Authors:  V G Edy; J Desmyter; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Interferon messenger RNA content of human fibroblasts during induction, shutoff, and superinduction of interferon production.

Authors:  P B Sehgal; B Dobberstein; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

4.  Purification of human diploid fibroblast interferon by immobilized neuraminidase.

Authors:  K P Fung; M H Ng
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Purification and partial characterization of human lymphoblast interferon.

Authors:  K C Zoon; M E Smith; P J Bridgen; D zur Nedden; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Glycosylation of human leukocyte interferon: effects of tunicamycin.

Authors:  K C Chadha; P M Grob; R L Hamill; E Sulkowski
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 8.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  Inducible expression of amplified human beta interferon genes in CHO cells.

Authors:  F McCormick; M Trahey; M Innis; B Dieckmann; G Ringold
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

10.  Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences.

Authors:  J Tavernier; R Derynck; W Fiers
Journal:  Nucleic Acids Res       Date:  1981-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.